Babczyńska M, Buliszak A, Marcjasz P, Bioły A, Borończyk A, Zając P. Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy. Qual Sport [Internet]. 2025 May 11 [cited 2025 Jun. 28];41:59986. Available from: https://apcz.umk.pl/QS/article/view/59986